Inhibitor Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 0.00 shares.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 0.00 shares.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2018 was 0.00 shares.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2017 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2020-12-31 | 0.00 shares 10-K · filed 2022-03-30 | |
| 2019-12-31 | 0.00 shares 10-K · filed 2021-03-26 | |
| 2018-12-31 | 0.00 shares 10-K · filed 2020-03-30 | |
| 2017-12-31 | 0.00 shares 10-K · filed 2018-02-16 | |
| 2016-12-31 | 0.00 shares 10-K · filed 2018-02-16 | |
| 2014-12-31 | 0.00 shares 10-K · filed 2015-02-13 | |
| 2013-12-31 | 0.00 shares 10-K · filed 2015-02-13 |